Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Leukocytosis
ADR ID BADD_A02517
ADR Hierarchy
01      Blood and lymphatic system disorders
01.02      White blood cell disorders
01.02.01      Leukocytoses NEC
01.02.01.002      Leukocytosis
Description A disorder characterized by laboratory test results that indicate an increased number of white blood cells in the blood. [CTCAE] A transient increase in the number of leukocytes in a body fluid. [MeSH]
MedDRA Code 10024378
MeSH ID D007964
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Leucocytosis NOS | Leukocytosis | Polymorphonuclear leucocytosis | Polymorphonuclear leukocytosis | Leukocytoses | Pleocytosis | Pleocytoses
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02505Gilteritinib0.000112%
BADD_D02517Enasidenib0.000437%
BADD_D02524Ivosidenib0.000168%
BADD_D02528Asciminib0.000246%
BADD_D02588Remdesivir0.000565%
The 11th Page    First    Pre   11    Total 11 Pages